Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Cost Effectiveness Modelling for Health Technology Assessment

A Practical Course
BuchGebunden
208 Seiten
Englisch
Springererschienen am22.08.20151st ed. 2015
This book provides an introduction to decision analytic cost-effectiveness modelling, giving the theoretical and practical knowledge required to design and implement analyses that meet the methodological standards of health technology assessment organisations.mehr
Verfügbare Formate
BuchGebunden
EUR106,99
BuchKartoniert, Paperback
EUR69,54
E-BookPDF1 - PDF WatermarkE-Book
EUR69,54

Produkt

KlappentextThis book provides an introduction to decision analytic cost-effectiveness modelling, giving the theoretical and practical knowledge required to design and implement analyses that meet the methodological standards of health technology assessment organisations.
Zusammenfassung
Provides a complete course textbook for cost effectiveness modelling in HTA

Covers the principles and practice of building stochastic decision tree and markov state models

Sets cost effectiveness modelling in the context of health technology assessment and reimbursement decision making

Includes supplementary material: sn.pub/extras
Details
ISBN/GTIN978-3-319-15743-6
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2015
Erscheinungsdatum22.08.2015
Auflage1st ed. 2015
Seiten208 Seiten
SpracheEnglisch
Gewicht496 g
IllustrationenXIII, 208 p. 86 illus., 3 illus. in color.
Artikel-Nr.15558981
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Cost Effectiveness Analysis and Health Technology Assessment: An overview. - Building a decision tree cost effectiveness model. - An introduction to sensitivity analysis in Cost Effectiveness Analysis. - Implementing Probabilistic Sensitivity Analysis in Excel®. - Outputs from Probabilistic Sensitivity Analysis-Part 1. - Introduction to Markov Cost Effectiveness Models. - Building a Markov Cost Effectiveness Model Part One - constructing the Markov structure. - Building a Markov Cost Effectiveness Model Part Two - Model Design Issues. - Probabilistic Sensitivity Analysis Effectiveness Parameters. - Probabilistic Sensitivity Analysis for Cost Parameters. - Probabilistic Sensitivity Analysis for Utility Parameters. - Probabilistic Sensitivity Analysis and Correlated Parameters - Cholesky Decomposition. - Outputs from Probabilistic Sensitivity Analysis - Part 2. - Understanding Health Care as an investment: Break Even Curves and Net Benefit Probability Maps. - Cost effectiveness analysisand risk sharing for innovative technologies - Technology Leasing Schemes. - Policy Responses to Uncertainty in Health Technology Appraisal. - Value of Information Analysis Part 1: The Cost of Making the Wrong Decision. - Value of Information Analysis Part 2: Investing in reduced uncertainty.âmehr

Schlagworte

Autor


Dr Richard Edlin , PhD is a Senior Lecturer based within the Health Systems section of the School of Population Health, University of Auckland, New Zealand.  Richard has published within both economics- and clinically-focused journals, including the top field journals in health economics.  Much of his research involves cost-effectiveness analysis. Richard leads teaching on postgraduate cost effectiveness.

 

Professor Christopher McCabe , PhD, holds a Capital Health Endowed Research Chair at the University of Alberta, having previously held Chairs at the Universities of Leeds, Warwick and Sheffield. He is on the health economics working group for Canadian Agency for Drugs and Technologies in Health (CADTH). He has acted as a consultant for public and private sector organizations in Europe, North America and Australasia; most notably with NICE in the UK. His primary research interest is in the development of efficient research and development processesfor biotherapies and devices in the context of value based reimbursement market access hurdles.

 

Professor Claire Hulme , PhD, holds a Chair in Health Economics and is head of the Academic Unit of Health Economics at the University of Leeds. She is on the National Institute of Health Research Health Technology Assessment Commissioning Panel in the UK. Her research interests lie in the economic evaluation of community programmes spanning the health and social care sectors, particularly economic evaluation alongside clinical trials.

 

Dr Peter Hall , MBChB, PhD, is a Senior Clinical Lecturer at the University of Edinburgh and a visiting Health Economist at the University of Leeds. He practices as a medical oncologist with an interest in breast cancer. His research interests include the use routine healthcare data, clinical pathway analysis and Bayesian decision modelling to inform efficient research design. He has an interest in the
economic evaluation of diagnostic tests and personalised medicine strategies. He is a past National Institute of Health and Clinical Excellence Scholar.

 

Judy Wright , MSc is a Senior Information Specialist and a qualified Librarian. Within her current role she leads the development of health research information support with a team of Information Specialists  located within the Academic Unit of Health Economics, University of Leeds. Judy manages a portfolio of activities supporting health economics research that includes custom-made literature searching, reference management and search methodology advice.

 
Weitere Artikel von
Edlin, Richard
Weitere Artikel von
McCabe, Christopher
Weitere Artikel von
Hulme, Claire